Back to News
Market Impact: 0.7

Stocks Recover on Government Reopening Hopes

SPYDIAQQQGMEDEXPEAKAMAFRMSOLVNWSAMNSTMCHPARMMRVLAMDONADIAMATKLACAVGOLRCXQCOMNTLATTWOOLEDXYZCNHBENASTSHHHIPGCARTOXYRKLBROIVSAROSTWDTSNNDAQ
Market Technicals & FlowsEconomic DataMonetary PolicyInterest Rates & YieldsFiscal Policy & BudgetCorporate EarningsCorporate Guidance & OutlookTax & Tariffs
Stocks Recover on Government Reopening Hopes

US equities ended mixed Friday, recovering early losses on optimism for a government shutdown resolution, despite ongoing economic concerns from weak consumer sentiment, hawkish Fed commentary, and disappointing Chinese trade data. The market also digested a mixed Q3 earnings season, characterized by high beat rates but decelerating growth, alongside the Supreme Court's skepticism on Trump-era tariffs which could lead to significant refunds. Notable individual movers included Globus Medical and Expedia surging on strong results, while semiconductor stocks like Microchip Technology and Take-Two Interactive declined on weaker outlooks or delays.

Analysis

US equities closed mixed on Friday, with the S&P 500 up +0.13% and Nasdaq 100 down -0.28%, recovering early losses on optimism for a government shutdown resolution. This rebound occurred despite Republicans rejecting Democrats' latest healthcare subsidy offer, highlighting market sensitivity to fiscal policy developments. However, broader economic concerns persisted, including the University of Michigan's US Nov consumer sentiment index falling to a 3.5-year low of 50.3 and October's US job cuts being the highest in over 20 years. Fed Vice Chair Jefferson's slightly hawkish comments, suggesting a slow approach to rate cuts, further tempered market expectations for aggressive monetary easing. Q3 corporate earnings presented a mixed picture, with 81% of S&P 500 companies beating forecasts, marking the best quarter since 2021. Yet, this was juxtaposed with projections for the smallest profit growth in two years at +7.2% y/y and decelerating sales growth to +5.9% y/y, indicating underlying fundamental pressures. Sectoral divergence was notable, with strong performers like Globus Medical (+35%) contrasting with widespread weakness in semiconductor stocks following Microchip Technology's (-5%) weak guidance. Further uncertainty looms from the Supreme Court's skepticism on the legality of President Trump's reciprocal tariffs, which could result in over $80 billion in refunds and reshape future trade policy. This, coupled with disappointing Chinese export data (-1.1% y/y), underscores ongoing global trade and regulatory risks.